Canaccord analyst George Gianarikas lowered the firm’s price target on Enovix (ENVX) to $21 from $22 and keeps a Buy rating on the shares. The firm noted the quarter introduced another delay in the “hockey stick” P&L they have been anticipating and tell investors to continue to be patient.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENVX:
- Enovix price target lowered to $21 from $22 at Canaccord
- Enovix’s Strategic Partnership with Honor: A Buy Rating Amidst Challenges and Opportunities
- Enovix Corporation Reports Strong Q3 2025 Results
- Enovix sees Q4 non-GAAP EPS (16c)-(20c), consensus (14c)
- Enovix reports Q3 EPS (14c), consensus (16c)